Granules Pharmaceuticals Inc. is recalling 71,424 bottles of Trazodone Hydrochloride (50 mg), a prescription medication used to treat depression. The recall was initiated because bottles may contain foreign tablets or capsules that are not the intended medication. If you are taking this medication, check your bottle immediately to ensure it only contains the correct tablets.
Taking a foreign tablet or capsule instead of the prescribed Trazodone could lead to serious adverse health effects, including unintended drug interactions or toxic reactions to an unknown substance.
You have 2 options:
Manufactured by Granules India Limited; Manufactured for Granules Pharmaceuticals Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.